Results 191 to 200 of about 1,463,708 (228)

Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics

Hypertension, 2022
Juan Gao, Daniel Kapusta
exaly  

Kappa opioid receptor ligands

2011
CARROLL FRANK IVY, NAVARRO HERMAN A, BRIEADDY LAWRENCE E, RUNYON SCOTT P, JAMES B THOMAS   +4 more
openaire   +5 more sources

Kappa opioid receptor antagonists

1995
G. Orosz, A. Z. Rónai, E. Kátay, K. Medzihradszky   +3 more
openaire   +4 more sources

The Therapeutic Potential of Novel Kappa Opioid Receptor-based Treatments

Current Medicinal Chemistry, 2020
Sebastiano Mercadante, Patrizia Romualdi   +1 more
exaly  

Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor

Cell, 2018
Brian Krumm, Ming-Yue Lee, Saheem Zaidi   +2 more
exaly  

Psychotomimetic Effects of Kappa Opioid Receptor Agonists

Biological Psychiatry, 2012
Kate L, White, Bryan L, Roth
openaire   +2 more sources

Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor

ACS Medicinal Chemistry Letters, 2017
Laura Bohn, Jeffrey Aube
exaly  

Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action

Proceedings of the National Academy of Sciences of the United States of America, 2009
Jay McLaughlin, Jane Aldrich
exaly  

Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy

ACS Chemical Neuroscience, 2012
Partha Ghosh, Thomas Prisinzano, John Streicher   +2 more
exaly  

Potent and highly selective kappa opioid receptor agonists incorporating chroman- and 2,3-dihydrobenzofuran-based constraints

Bioorganic and Medicinal Chemistry Letters, 2005
Patrick J Little, Roland E Dolle, Robert N Dehaven   +2 more
exaly